首页|不同剂量替罗非班在急性心肌梗死患者急诊介入治疗中的应用价值

不同剂量替罗非班在急性心肌梗死患者急诊介入治疗中的应用价值

扫码查看
目的::对急性ST段抬高性心肌梗死(ASTEMI)患者介入(PCI)治疗中替罗非班的应用价值分析。方法:临床选取我院在2012年1月-2013年1月实施治疗的66例急性ST段抬高性心肌梗死患者,并将其分成两组,其中对照组患者介入治疗过程中给予低剂量替罗非班,观察组患者介入治疗过程中给予高剂量替罗非班,对比分析两组患者不良反应及预后效果。结果:观察组患者的不良反应率和对照组相比差异不明显(P>0.05);治疗18个月后观察组患者的预后效果显著优于对照组,差异显著(P<0.05)。结论:高剂量替罗非班在急性心肌梗死患者介入治疗中的应用,能够显著改善患者预后效果,值得推广应用。
objective to acute st- elevation myocardial infarction (ASTEMI) intervention (PCI) in patients with treatment for had the application value of class analysis. Methods clinical selection of the hospital in January 2012 - January 2013 the implementation of treatment of 66 patients with acute st- elevation myocardial infarction (mi), and is divided into two groups, the control group in the process of interventional therapy in patients with low dose had class for observation group patients give high dose in the process of inter-ventional therapy for class had, compared two groups of patients with adverse reactions and the effect of prognosis. Results observation group of patients with adverse reaction rate and the control group compared with the difference is not obvious (P>0.05);The prognosis of patients with 18 months after treatment group effect is significantly better than control group, significant difference (P<0.05). Con-clusion high dose for class had in the application of interventional therapy in patients with acute myocardial infarction, can significantly improve the prognosis of patients with the effect, is worthy of popularization and application.

for class hadInterventional therapyAcute myocardial infarction

樊维娜、王建新、许岭平、刘杲

展开 >

咸阳市中心医院心内二科 712000

替罗非班 介入治疗 急性心肌梗死

2015

延边医学

延边医学

ISSN:
年,卷(期):2015.(7)
  • 10